We have 5 of 48 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Leukodystrophies are inherited neurodegenerative disorders characterized by progressive white matter damage, historically lacking effective treatments beyond symptomatic management and hematopoietic stem cell transplantation. This review analyzes contemporary biotechnological strategies, including gene therapy, cell-ba...
An analysis of clinical trial data shows that combination approaches that combine cellular therapy with immune checkpoint inhibitors or standard treatments are the most effective, highlighting the need for further research in personalized immunotherapy for melanoma.
Development of safe-harbor integration and B2M/CIITA-based hypoimmunogenic designs as strategies to reduce engineering-related batch variability and HLA-dependent donor variability support a transition from empirical optimized MSC preparations toward molecularly defined cellular medicines with predefined genotype, expr...
This review provides a roadmap for translational decision-making and identifies critical gaps that must be addressed before MSC-based therapies can be integrated into routine neurological practice.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
